MARKET

GNVR

GNVR

Genvor Inc
OTCMQB
0.400
NaN%
Closed 09:30 05/20 EDT
OPEN
--
PREV CLOSE
0.400
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.000
52 WEEK LOW
0.014
MARKET CAP
14.48M
P/E (TTM)
-9.9010
1D
5D
1M
3M
1Y
5Y
1D
Genvor Q3 net loss widens 43.68% to $429,567; reports no revenue
PUBT · 05/13 20:27
Genvor issues 1 share of Series C preferred stock to Brio Advisory Group
PUBT · 05/11 21:29
Genvor sells Evergreen $800,000 convertible note, issues warrants for up to $666,668
PUBT · 04/22 15:49
Genvor signs MOU with Canlab International to advance commercial peptide pipeline
PUBT · 04/14 12:07
Genvor CEO to present at Centri Capital Conference at Nasdaq
Reuters · 04/07 17:03
Genvor CEO Chad Pawlak to Present at NIBA 152nd Investment Conference in Fort Lauderdale
Reuters · 03/05 13:05
Genvor Expands Into Consumer Health and Wellness Market
Reuters · 03/04 13:01
GENVOR ANNOUNCES STRATEGIC EXPANSION INTO HEALTH AND WELLNESS MARKET, LEVERAGING PROPRIETARY AI-ACCELERATED BIOCYPHER PLATFORM TO DEVELOP CONSUMER PEPTIDE SOLUTIONS
Reuters · 03/04 13:00
More
About GNVR
Genvor Incorporated is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through biological foliar application as well as transgenic seed traits. The Company’s proprietary BioCypher Algorithm combines computational biology, machine learning, and regulatory benchmarks to create peptides that optimize agricultural outcomes with biological safety. With multiple patents and proprietary peptides in active development, it offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks. The Company’s platform centers on the development of anti-microbial peptides (AMPs), which are designed to combat a broad spectrum of debilitating and destructive plant diseases including bacterial, fungal, and viral pathogens that threaten crop productivity worldwide.

Webull offers Genvor Inc stock information, including OTCMQB: GNVR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNVR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNVR stock methods without spending real money on the virtual paper trading platform.